| A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing M Prapa, S Caldrer, C Spano, M Bestagno, G Golinelli, G Grisendi, ... Oncotarget 6 (28), 24884, 2015 | 102 | 2015 |
| Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors G Golinelli, G Grisendi, M Prapa, M Bestagno, C Spano, F Rossignoli, ... Cancer gene therapy 27 (7), 558-570, 2020 | 96 | 2020 |
| Soluble TRAIL armed human MSC as gene therapy for pancreatic cancer C Spano, G Grisendi, G Golinelli, F Rossignoli, M Prapa, M Bestagno, ... Scientific reports 9 (1), 1788, 2019 | 70 | 2019 |
| Detection of microparticles from human red blood cells by multiparametric flow cytometry G Grisendi, E Finetti, D Manganaro, N Cordova, G Montagnani, C Spano, ... Blood Transfusion 13 (2), 274, 2015 | 66 | 2015 |
| Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas G Grisendi, C Spano, N D'souza, V Rasini, E Veronesi, M Prapa, ... Stem Cells 33 (3), 859-869, 2015 | 66 | 2015 |
| GD2 CAR T cells against human glioblastoma M Prapa, C Chiavelli, G Golinelli, G Grisendi, M Bestagno, R Di Tinco, ... NPJ precision oncology 5 (1), 93, 2021 | 59 | 2021 |
| GD2 expression in breast cancer G Orsi, M Barbolini, G Ficarra, G Tazzioli, P Manni, T Petrachi, I Mastrolia, ... Oncotarget 8 (19), 31592, 2017 | 50 | 2017 |
| Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers M Prapa, D Cerioli, S Caldrer, C Spano, M Bestagno, G Golinelli, ... Cytotherapy 18 (6), 2016 | 16 | 2016 |
| Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma G Golinelli, G Grisendi, M Dall'Ora, G Casari, C Spano, R Talami, ... Translational Oncology 15 (1), 101240, 2022 | 15 | 2022 |
| Developing cell therapies as drug products R Ciccocioppo, P Comoli, G Astori, F Del Bufalo, M Prapa, M Dominici, ... British Journal of Pharmacology 178 (2), 262-279, 2021 | 6 | 2021 |
| Soluble TRAIL-Armed Human AD-MSC as Novel Cell Therapy: Approach for Pancreatic Ductal Adenocarcinoma C Spano, G Grisendi, O Candini, G Golinelli, T Petrachi, F Rossignoli, ... Cytotherapy 18 (6), S24-S25, 2016 | 3 | 2016 |
| Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma C Chiavelli, M Prapa, G Rovesti, M Silingardi, G Neri, G Pugliese, L Trudu, ... NPJ Precision Oncology 8 (1), 26, 2024 | 2 | 2024 |
| Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells G Casari, M Dall'Ora, A Melandri, V Masciale, C Chiavelli, M Prapa, ... Cytotherapy 25 (6), 605-614, 2023 | 2 | 2023 |
| ASISTENCA INFERMIERORE POSTOPERATORE KV Lila Shundi3 Albana Qefalia1 , Etleva Rustami2 , Alma Pula2 , Malvina Prapa3 Konferenca e “Fakulteti i Shkencave Mjekësore Teknike” Universiteti i Mjekësisë, 2023 | | 2023 |
| AUTOLOGOUS ANTI-GD2 CAR-T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA C Chiavelli, G Rovesti, M Prapa, G Neri, G Pugliese, L Trudu, M Silingardi, ... HUMAN GENE THERAPY 34 (21-22), A42-A43, 2023 | | 2023 |
| NDERLIKIMET E HERSHME POSTOPERATORE EV M. Agolli MD/PhD3 K. Vakeflliu MSc*1,2, B. Kaleci PhD1, M. Prapa PhD1 International Congress of Healthcare Professionals, ISBN: 9789928381095, 2023 | | 2023 |
| Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER G Neri, C Chiavelli, L Trudu, M Prapa, G Golinelli, G Pugliese, ... Cytotherapy 25 (6), 2023 | | 2023 |
| Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA C Chiavelli, M Prapa, G Neri, G Pugliese, G Rovesti, L Trudu, G Grisendi, ... Cytotherapy 24 (5), 2022 | | 2022 |
| 5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma G Golinelli, G Grisendi, M Dall'Ora, G Casari, M Prapa, C Spano, R Talami, ... Annals of Oncology 32, S2, 2021 | | 2021 |
| Cellule Primarie da Glioblastoma Multiforme: Isolamento in Vitro, Caratterizzazione Fenotipica ed Analisi Molecolare Volta a Definire i Livelli di Staminalità C SAUTTO | | 2019 |
